Comparaciones Financieras Regeneron Pharmaceuticals, Inc.
Acciones
REGN
US75886F1075
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
681,58 USD | -1,68 % | -4,93 % | -4,32 % |
16/01 | REGENERON PHARMACEUTICALS, INC. : UBS da una recomendación neutral | ZM |
14/01 | Yancopoulos, CSO de Regeneron, habla de los fármacos para perder peso y de la cartera de productos en desarrollo | MT |
Añadir a una lista 0 seleccionado | Ventas netas | Margen neto | Margen Operativo | ROE | ROA | Apalancamiento (Dette/EBITDA) | |
---|---|---|---|---|---|---|---|
13 117 200 000,00 | +30.14% | +39.08% | 20.74x | 16.2x | -1.6x | ||
9 869 200 000,00 | +36.68% | +44.33% | 22.99x | 17.71x | -2.46x | ||
1 217 670 819,47 | -23.26% | -33.51% | -8.54x | -7.69x | 10.14x | ||
3 971 505 823,63 | +24.36% | +18.08% | 4.62x | 4.02x | -13.1x | ||
2 458 779 000,00 | -35.86% | -49.12% | -22.26x | -14.47x | 2.05x | ||
5 525 381 027,26 | +26.50% | +29.43% | 18.99x | 15.45x | -0.64x | ||
1 887 100 000,00 | +13.23% | +13.30% | 12.68x | 8.89x | -5.76x | ||
2 296 847 376,90 | +26.42% | +32.30% | 14.78x | 13.31x | -5.01x | ||
305 208 000,00 | -245.59% | -232.51% | - | -50.2x | -0.8x | ||
1 243 336 000,00 | -43.11% | -21.54% | -86.15x | -1.86x | 1.96x | ||
1 830 208 000,00 | +11.35% | +9.34% | 8.74x | 6.91x | -5.06x | ||
2 333 139 980,82 | +19.96% | +24.97% | 9.02x | 6.41x | -0.78x | ||
277 368 968,39 | -180.51% | -170.79% | -818.43x | -50.27x | -0.33x | ||
156 178 000,06 | -12.22% | -37.48% | -3.46x | -2.93x | 11.91x | ||
47 792 383,07 | -205.30% | -166.94% | -58.43x | - | 2.98x | ||
619 949 732,91 | +44.81% | +45.26% | 55.36x | 27.64x | 0.65x | ||
Promedio | 2.947.304.069,53 | -32,02 % | -28,49 % | -55,29x | -0,73x | -0,37x | |
Media ponderada por Capi. | 6.327.195.785,11 | +0,81 % | +4,27 % | -7,89x | 6,42x | -1,00x |
- Bolsa de valores
- Acciones
- Acción REGN
- Sector Regeneron Pharmaceuticals, Inc.
- Comparaciones Financieras
MarketScreener is also available in this country: United States.
Switch edition